4//SEC Filing
Conn Morgan 4
Accession 0001062993-25-005294
CIK 0001850119other
Filed
Mar 11, 8:00 PM ET
Accepted
Mar 12, 7:31 PM ET
Size
7.3 KB
Accession
0001062993-25-005294
Insider Transaction Report
Form 4
Conn Morgan
Chief Finanical Officer
Transactions
- Award
Common Stock
2025-03-11+19,500→ 79,648 total - Award
Stock Option (right to buy)
2025-03-11+19,500→ 19,500 totalExercise: $0.60Exp: 2035-03-11→ Common Stock (19,500 underlying)
Footnotes (2)
- [F1]Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs vest 25% on March 11, 2026, with the remaining 75% vesting on a quarterly basis for the three years thereafter, in each case subject the Reporting Person's continued service through the applicable vesting date. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock.
- [F2]The option vests 25% on March 11, 2026, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service through each applicable vesting date.
Issuer
Century Therapeutics, Inc.
CIK 0001850119
Entity typeother
Related Parties
1- filerCIK 0001974124
Filing Metadata
- Form type
- 4
- Filed
- Mar 11, 8:00 PM ET
- Accepted
- Mar 12, 7:31 PM ET
- Size
- 7.3 KB